SCHEMBL29958412

SCHEMBL29958412

Cc1cc(N)nc(C)c1CNc1cc(OCc2cn3cc(C4CC4)ccc3n2)ccn1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.36
▸ MAP4K1 Q92918 2/20 0.34
▸ METTL3 Q86U44 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27033615 1.00 KLKB1 (0.36) KLKB1MAP4K1METTL3
SCHEMBL29957930 0.87 KLKB1 (0.36) KLKB1MAP4K1METTL3
SCHEMBL27033979 0.87 KLKB1 (0.36) KLKB1MAP4K1METTL3
SCHEMBL29958491 0.86 KLKB1 (0.40) KLKB1MAP4K1
SCHEMBL27033643 0.86 KLKB1 (0.40) KLKB1MAP4K1
SCHEMBL29958167 0.85 KLKB1 (0.40) KLKB1MAP4K1METTL3
SCHEMBL27033770 0.82 KLKB1 (0.35) KLKB1METTL3
SCHEMBL29141803 0.80 CLK4 (0.40) METTL3
SCHEMBL24729668 0.80 METTL3 (0.39) KLKB1METTL3
SCHEMBL24729569 0.79 METTL3 (0.39) KLKB1METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308228-A1 PLASMA KALLIKREIN INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
WO-2022197756-A1 PLASMA KALLIKREIN INHIBITORS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback